
USA - NASDAQ:UTRS - US60343F2056 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to UTRS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-03 | Piper Sandler | Maintains | Overweight |
| 2022-08-10 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2022-08-10 | Piper Sandler | Maintains | Overweight |
| 2022-05-12 | SVB Leerink | Maintains | Outperform |
| 2022-05-12 | Piper Sandler | Maintains | Overweight |
| 2022-03-09 | Piper Sandler | Maintains | Overweight |
| 2021-12-03 | SVB Leerink | Maintains | Outperform |
| 2021-11-16 | UBS | Initiate | Buy |
| 2021-11-16 | SVB Leerink | Initiate | Outperform |
| 2021-11-16 | JP Morgan | Initiate | Overweight |
| 2021-11-16 | Piper Sandler | Initiate | Overweight |
7 analysts have analysed UTRS and the average price target is 3.06 USD. This implies a price increase of 106.76% is expected in the next year compared to the current price of 1.48.
The consensus rating for MINERVA SURGICAL INC (UTRS) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.